Up-regulation of hMUTYH, a DNA repair enzyme, in the mitochondria of substantia nigra in Parkinson's disease

被引:48
|
作者
Arai, Takeo
Fukae, Jiro
Hatano, Taku
Kubo, Shin-ichiro
Ohtsubo, Toshio
Nakabeppu, Yusaku
Mori, Hideo
Mizuno, Yoshikuni
Hattori, Nobutaka
机构
[1] Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138421, Japan
[2] Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Neurofunct Genom, Fukuoka 8128582, Japan
关键词
Parkinson's disease; oxidative stress; hMUTYH; DNA repair enzyme;
D O I
10.1007/s00401-006-0081-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is ample evidence for the involvement of oxidative stress in mitochondrial DNA damage and repair mechanisms in Parkinson's disease (PD). The human MutY homolog (hMUTYH) which removes misincorporated adenine opposite 8-oxoG in DNA functions in post-replication, and is localized in the nuclei and mitochondria. We hypothesized that hMUTYH is involved in the disease process of PD. To test our hypothesis, we performed immunohistochemical and biochemical studies on brains of patients with PD and those of control patients. Our results showed up-regulation of hMUTYH in the mitochondria of the SN of PD patients. Western blot analysis also revealed high hMUTYH levels in PD patients and expression of a 47-kDa molecule in the brains as the major isoform. This molecule was localized within the mitochondria as confirmed by double staining with a mitochondrial marker. To confirm the presence of this molecule, we examined the mRNAs of isoforms that translate to the 47-kDa molecule. Based on the amount of mRNAs, the major molecule was alpha 4. Interestingly, this molecule lacks the mitochondria targeting sequence. Our results suggest that hMUTYH might be a useful marker of oxidative stress and that oxidative stress and genomic instability are important in the PD disease process.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 50 条
  • [1] Up-regulation of hMUTYH, a DNA repair enzyme, in the mitochondria of substantia nigra in Parkinson’s disease
    Takeo Arai
    Jiro Fukae
    Taku Hatano
    Shin-ichiro Kubo
    Toshio Ohtsubo
    Yusaku Nakabeppu
    Hideo Mori
    Yoshikuni Mizuno
    Nobutaka Hattori
    Acta Neuropathologica, 2006, 112 : 139 - 145
  • [2] Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease
    Simon, DK
    Lin, MT
    Zheng, LY
    Liu, GJ
    Ahn, CH
    Kim, LM
    Mauck, WM
    Twu, F
    Beal, MF
    Johns, DR
    NEUROBIOLOGY OF AGING, 2004, 25 (01) : 71 - 81
  • [3] Hyperechogenicity of the substantia nigra in Parkinson's disease
    Ressner, Pavel
    Skoloudik, David
    Hlustik, Petr
    Kanovsky, Petr
    JOURNAL OF NEUROIMAGING, 2007, 17 (02) : 164 - 167
  • [4] Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease
    R. K. B. Pearce
    A. Owen
    S. Daniel
    P. Jenner
    C. D. Marsden
    Journal of Neural Transmission, 1997, 104 : 661 - 677
  • [5] Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease
    Pearce, RKB
    Owen, A
    Daniel, S
    Jenner, P
    Marsden, CD
    JOURNAL OF NEURAL TRANSMISSION, 1997, 104 (6-7) : 661 - 677
  • [6] Proteome analysis of human substantia nigra in Parkinson's disease
    Basso, M
    Giraudo, S
    Corpillo, D
    Bergamasco, B
    Lopiano, L
    Fasano, M
    PROTEOMICS, 2004, 4 (12) : 3943 - 3952
  • [7] Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease
    Faucheux, BA
    Martin, ME
    Beaumont, C
    Hunot, S
    Hauw, JJ
    Agid, Y
    Hirsch, EC
    JOURNAL OF NEUROCHEMISTRY, 2002, 83 (02) : 320 - 330
  • [8] Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
    Trist, Benjamin G.
    Hare, Dominic J.
    Double, Kay L.
    AGING CELL, 2019, 18 (06)
  • [9] Proteasomal function is impaired in substantia nigra in Parkinson's disease
    McNaught, KSP
    Jenner, P
    NEUROSCIENCE LETTERS, 2001, 297 (03) : 191 - 194
  • [10] α-synuclein expression in substantia nigra and cortex in Parkinson's disease
    Neystat, M
    Lynch, T
    Przedborski, S
    Kholodilov, N
    Rzhetskaya, M
    Burke, RE
    MOVEMENT DISORDERS, 1999, 14 (03) : 417 - 422